Alnylam Pharmaceuticals, Inc. (ALNY)
USD 222.68
(-5.54%)
USD 222.68
(-5.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -440.24 Million USD | 61.08% |
| 2022 | -1.13 Billion USD | -32.64% |
| 2021 | -852.82 Million USD | 0.64% |
| 2020 | -858.28 Million USD | 3.14% |
| 2019 | -886.11 Million USD | -16.37% |
| 2018 | -761.49 Million USD | -55.13% |
| 2017 | -490.87 Million USD | -19.69% |
| 2016 | -410.1 Million USD | -41.38% |
| 2015 | -290.07 Million USD | 19.51% |
| 2014 | -360.39 Million USD | -303.92% |
| 2013 | -89.22 Million USD | 15.84% |
| 2012 | -106.01 Million USD | -83.9% |
| 2011 | -57.64 Million USD | -32.48% |
| 2010 | -43.51 Million USD | 8.56% |
| 2009 | -47.59 Million USD | -81.3% |
| 2008 | -26.24 Million USD | 69.29% |
| 2007 | -85.46 Million USD | -146.95% |
| 2006 | -34.6 Million USD | 19.35% |
| 2005 | -42.91 Million USD | -31.42% |
| 2004 | -32.65 Million USD | -30.44% |
| 2003 | -25.03 Million USD | -505.25% |
| 2002 | -4.13 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -111.57 Million USD | -560.61% |
| 2024 Q1 | -65.93 Million USD | 52.18% |
| 2024 Q2 | -16.88 Million USD | 74.39% |
| 2023 Q4 | -137.87 Million USD | -193.31% |
| 2023 Q3 | 147.75 Million USD | 153.53% |
| 2023 Q2 | -276.02 Million USD | -58.54% |
| 2023 Q1 | -174.1 Million USD | 16.09% |
| 2023 FY | -440.24 Million USD | 61.08% |
| 2022 Q4 | -207.49 Million USD | 48.88% |
| 2022 Q1 | -240.34 Million USD | 7.01% |
| 2022 Q2 | -277.4 Million USD | -15.42% |
| 2022 FY | -1.13 Billion USD | -32.64% |
| 2022 Q3 | -405.92 Million USD | -46.33% |
| 2021 Q2 | -189.55 Million USD | 5.36% |
| 2021 Q3 | -204.51 Million USD | -7.89% |
| 2021 FY | -852.82 Million USD | 0.64% |
| 2021 Q4 | -258.46 Million USD | -26.38% |
| 2021 Q1 | -200.29 Million USD | 17.76% |
| 2020 Q2 | -179.22 Million USD | 1.64% |
| 2020 Q4 | -243.54 Million USD | 3.85% |
| 2020 Q3 | -253.29 Million USD | -41.32% |
| 2020 FY | -858.28 Million USD | 3.14% |
| 2020 Q1 | -182.22 Million USD | 34.02% |
| 2019 Q4 | -276.18 Million USD | -32.44% |
| 2019 FY | -886.11 Million USD | -16.37% |
| 2019 Q2 | -219.48 Million USD | -20.65% |
| 2019 Q1 | -181.91 Million USD | 13.96% |
| 2019 Q3 | -208.53 Million USD | 4.99% |
| 2018 Q3 | -245.28 Million USD | -49.96% |
| 2018 Q4 | -211.44 Million USD | 13.8% |
| 2018 FY | -761.49 Million USD | -55.13% |
| 2018 Q1 | -141.21 Million USD | 0.71% |
| 2018 Q2 | -163.56 Million USD | -15.82% |
| 2017 FY | -490.87 Million USD | -19.69% |
| 2017 Q2 | -118.42 Million USD | -10.37% |
| 2017 Q4 | -142.22 Million USD | -15.69% |
| 2017 Q3 | -122.93 Million USD | -3.81% |
| 2017 Q1 | -107.29 Million USD | 5.0% |
| 2016 Q4 | -112.93 Million USD | -8.52% |
| 2016 Q2 | -90.12 Million USD | 12.47% |
| 2016 FY | -410.1 Million USD | -41.38% |
| 2016 Q1 | -102.97 Million USD | -13.51% |
| 2016 Q3 | -104.07 Million USD | -15.47% |
| 2015 Q2 | -71.78 Million USD | -41.37% |
| 2015 Q4 | -90.72 Million USD | -18.14% |
| 2015 Q3 | -76.79 Million USD | -6.98% |
| 2015 FY | -290.07 Million USD | 19.51% |
| 2015 Q1 | -50.77 Million USD | -137.4% |
| 2014 Q2 | -44.07 Million USD | 82.44% |
| 2014 Q3 | -43.98 Million USD | 0.19% |
| 2014 Q4 | -21.38 Million USD | 51.38% |
| 2014 FY | -360.39 Million USD | -303.92% |
| 2014 Q1 | -250.94 Million USD | -675.54% |
| 2013 Q3 | -29.68 Million USD | -63.39% |
| 2013 Q1 | -9.01 Million USD | 85.51% |
| 2013 Q2 | -18.16 Million USD | -101.59% |
| 2013 FY | -89.22 Million USD | 15.84% |
| 2013 Q4 | -32.35 Million USD | -9.0% |
| 2012 Q4 | -62.18 Million USD | -218.88% |
| 2012 Q1 | -11.36 Million USD | 20.52% |
| 2012 Q3 | -19.5 Million USD | -50.52% |
| 2012 FY | -106.01 Million USD | -83.9% |
| 2012 Q2 | -12.95 Million USD | -13.97% |
| 2011 Q4 | -14.3 Million USD | -8.05% |
| 2011 Q2 | -13.82 Million USD | 15.11% |
| 2011 Q1 | -16.28 Million USD | -134.99% |
| 2011 FY | -57.64 Million USD | -32.48% |
| 2011 Q3 | -13.23 Million USD | 4.25% |
| 2010 Q3 | -9.63 Million USD | 34.19% |
| 2010 FY | -43.51 Million USD | 8.56% |
| 2010 Q1 | -12.32 Million USD | -58.17% |
| 2010 Q2 | -14.63 Million USD | -18.74% |
| 2010 Q4 | -6.93 Million USD | 28.04% |
| 2009 FY | -47.59 Million USD | -81.3% |
| 2009 Q4 | -7.79 Million USD | 15.39% |
| 2009 Q3 | -9.2 Million USD | 59.44% |
| 2009 Q2 | -22.7 Million USD | -187.77% |
| 2009 Q1 | -7.88 Million USD | 16.0% |
| 2008 Q1 | -1.23 Million USD | -174.55% |
| 2008 Q4 | -9.39 Million USD | -228.62% |
| 2008 Q3 | -2.85 Million USD | 77.6% |
| 2008 FY | -26.24 Million USD | 69.29% |
| 2008 Q2 | -12.76 Million USD | -929.86% |
| 2007 Q2 | -12.69 Million USD | 41.37% |
| 2007 Q4 | 1.66 Million USD | 103.15% |
| 2007 FY | -85.46 Million USD | -146.95% |
| 2007 Q1 | -21.64 Million USD | -156.52% |
| 2007 Q3 | -52.79 Million USD | -315.98% |
| 2006 Q3 | -7.4 Million USD | 25.33% |
| 2006 Q4 | -8.43 Million USD | -14.03% |
| 2006 Q1 | -8.86 Million USD | 38.86% |
| 2006 FY | -34.6 Million USD | 19.35% |
| 2006 Q2 | -9.91 Million USD | -11.85% |
| 2005 Q1 | -6.6 Million USD | -15.79% |
| 2005 Q4 | -14.49 Million USD | -35.71% |
| 2005 FY | -42.91 Million USD | -31.42% |
| 2005 Q3 | -10.67 Million USD | 4.19% |
| 2005 Q2 | -11.14 Million USD | -68.86% |
| 2004 Q1 | -13.58 Million USD | -117.03% |
| 2004 Q2 | -6.95 Million USD | 48.79% |
| 2004 FY | -32.65 Million USD | -30.44% |
| 2004 Q4 | -5.7 Million USD | 11.16% |
| 2004 Q3 | -6.41 Million USD | 7.76% |
| 2003 FY | -25.03 Million USD | -505.25% |
| 2003 Q4 | -6.25 Million USD | 0.0% |
| 2003 Q2 | -3.24 Million USD | -50.81% |
| 2003 Q3 | -6.25 Million USD | -92.91% |
| 2003 Q1 | -2.15 Million USD | 0.0% |
| 2002 FY | -4.13 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -200.716% |
| Alkermes plc | 355.75 Million USD | 223.748% |
| Agenus Inc. | -245.76 Million USD | -79.134% |
| Aptorum Group Limited | -2.82 Million USD | -15485.735% |
| Ardelyx, Inc. | -66.06 Million USD | -566.357% |
| Dyadic International, Inc. | -6.79 Million USD | -6378.471% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -46934.402% |
| Lantern Pharma Inc. | -15.96 Million USD | -2658.143% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2213.546% |
| Novavax, Inc. | -545.06 Million USD | 19.231% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -655.223% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -496.615% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2273.772% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -4308.592% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -646.392% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -17.828% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1708.771% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1079.009% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -167.504% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -500.218% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2069.642% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -607.159% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1255.216% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -232.276% |
| AlloVir, Inc. | -190.41 Million USD | -131.198% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -114.464% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1447.315% |
| Bicycle Therapeutics plc | -180.66 Million USD | -143.68% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -145.872% |
| ChromaDex Corporation | -4.93 Million USD | -8815.391% |
| Chimerix, Inc. | -82.09 Million USD | -436.259% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -887.016% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -331.314% |
| CRISPR Therapeutics AG | -153.61 Million USD | -186.597% |
| Precision BioSciences, Inc. | -61.31 Million USD | -617.954% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -173.565% |
| Fortress Biotech, Inc. | -60.63 Million USD | -626.029% |
| Fortress Biotech, Inc. | -60.63 Million USD | -626.029% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -439.645% |
| ImmuCell Corporation | -5.77 Million USD | -7523.769% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -289.729% |
| Immix Biopharma, Inc. | -15.42 Million USD | -2753.887% |
| Incyte Corporation | 597.59 Million USD | 173.668% |
| Innoviva, Inc. | 179.72 Million USD | 344.957% |
| IO Biotech, Inc. | -86.08 Million USD | -411.416% |
| Jaguar Health, Inc. | -41.3 Million USD | -965.961% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -187.755% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 944.119% |
| ContextLogic Inc. | -317 Million USD | -38.878% |
| MiMedx Group, Inc. | 67.43 Million USD | 752.8% |
| MEI Pharma, Inc. | 17.77 Million USD | 2576.33% |
| NextCure, Inc. | -62.72 Million USD | -601.883% |
| Onconetix, Inc. | -37.4 Million USD | -1076.813% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1015.13% |
| Opthea Limited | -220.24 Million USD | -99.89% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -760.536% |
| Vaxcyte, Inc. | -402.26 Million USD | -9.441% |
| PDS Biotechnology Corporation | -42.94 Million USD | -925.197% |
| Precigen, Inc. | -95.9 Million USD | -359.044% |
| Pharming Group N.V. | -10.54 Million USD | -4073.701% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -118.383% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1693.758% |
| PureTech Health plc | -65.69 Million USD | -570.11% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1654.581% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -107.446% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1708.771% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -70.748% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1516.279% |
| Acelyrin, Inc. | -381.64 Million USD | -15.355% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -3509848.823% |
| Summit Therapeutics Inc. | -614.92 Million USD | 28.408% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1190.994% |
| Senti Biosciences, Inc. | -92.91 Million USD | -373.791% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -320.483% |
| Elevation Oncology, Inc. | -45.7 Million USD | -863.246% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1152.823% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3267.859% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -6485.52% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1399.36% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5078.708% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -665.465% |
| Seer, Inc. | -86.27 Million USD | -410.266% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -557.127% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -569.417% |
| ESSA Pharma Inc. | -26.58 Million USD | -1556.144% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1093.087% |
| GT Biopharma, Inc. | -7.59 Million USD | -5694.945% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -82.4% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -747.842% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 716.499% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -708.941% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -796.258% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -4325.545% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 23.148% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -12169.844% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -762.239% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -79.255% |
| Aptose Biosciences Inc. | -51.2 Million USD | -759.73% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -347.865% |
| Soligenix, Inc. | -6.14 Million USD | -7069.213% |
| Century Therapeutics, Inc. | -136.67 Million USD | -222.113% |
| Kura Oncology, Inc. | -152.63 Million USD | -188.436% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -393.445% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4077.662% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 77954.174% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -77271.178% |
| Autolus Therapeutics plc | -208.38 Million USD | -111.266% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -512.315% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -521.855% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1931.761% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -95.446% |
| GRI Bio, Inc. | -13.03 Million USD | -3276.866% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -10547.81% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -254.794% |
| IGM Biosciences, Inc. | -246.41 Million USD | -78.658% |
| INmune Bio, Inc. | -30 Million USD | -1367.082% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -298.196% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -943.381% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2658.122% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2687.227% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -637.609% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -335.164% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -59.435% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -85.06% |
| Verastem, Inc. | -87.36 Million USD | -403.9% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -712.434% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -172.873% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -277.378% |
| Histogen Inc. | -10.62 Million USD | -4045.015% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -2981.469% |
| Surrozen, Inc. | -43.04 Million USD | -922.82% |
| Organovo Holdings, Inc. | -14.67 Million USD | -2900.763% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -8554.207% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -741.136% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1642.635% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1534.279% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -5167.889% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -191.387% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -799.811% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1381.05% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4125.902% |
| Apollomics, Inc. | -172.6 Million USD | -155.063% |
| Amarin Corporation plc | -59.11 Million USD | -644.759% |
| Mesoblast Limited | -87.95 Million USD | -400.525% |
| Turnstone Biologics Corp. | -55.2 Million USD | -697.54% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -199.562% |
| Synaptogenix, Inc. | -6.03 Million USD | -7190.581% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2616.202% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -464.268% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9088.044% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -5139.606% |
| Exelixis, Inc. | 207.76 Million USD | 311.894% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1007.248% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -205.834% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 16.72% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3516.833% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -5547.973% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1331.728% |
| Gritstone bio, Inc. | -138.49 Million USD | -217.887% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -582.916% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -10906.188% |
| Avid Bioservices, Inc. | -140.75 Million USD | -212.776% |
| Insmed Incorporated | -749.56 Million USD | 41.267% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -2798.33% |
| MediWound Ltd. | -6.71 Million USD | -6455.122% |
| OmniAb, Inc. | -50.61 Million USD | -769.717% |
| Alector, Inc. | -130.39 Million USD | -237.632% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -287.114% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -749.118% |
| Zai Lab Limited | -334.62 Million USD | -31.565% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -35.883% |
| Aura Biosciences, Inc. | -76.4 Million USD | -476.173% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -87.631% |
| Immunic, Inc. | -93.61 Million USD | -370.284% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -223.962% |
| Veracyte, Inc. | -74.4 Million USD | -491.691% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -5635.641% |
| FibroGen, Inc. | -284.23 Million USD | -54.888% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1578.263% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6187.474% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2237.647% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 206.125% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1851.86% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 993.511% |
| TG Therapeutics, Inc. | 12.67 Million USD | 3574.132% |
| Galecto, Inc. | -38.34 Million USD | -1047.988% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2233.521% |
| Fortrea Holdings Inc. | -3.4 Million USD | -12848.294% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -247.622% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2428.528% |
| XBiotech Inc. | -24.55 Million USD | -1692.735% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -582.916% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -602.364% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -347.282% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1954.613% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -697.641% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 27.429% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -544.996% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -773149.728% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -94.334% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1877.059% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -100.374% |
| NexImmune, Inc. | -32.34 Million USD | -1261.108% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -8227.548% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3034.311% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 111.135% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1717.605% |
| Scopus BioPharma Inc. | -11.6 Million USD | -3691.977% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -276.926% |
| Ainos, Inc. | -13.77 Million USD | -3096.982% |
| Pluri Inc. | -20.88 Million USD | -2007.631% |
| Prothena Corporation plc | -147.02 Million USD | -199.427% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -286.615% |
| Celularity Inc. | -196.29 Million USD | -124.276% |
| Rallybio Corporation | -74.56 Million USD | -490.422% |
| Cue Biopharma, Inc. | -50.73 Million USD | -767.763% |
| MeiraGTx Holdings plc | -84.02 Million USD | -423.929% |
| Omeros Corporation | -117.81 Million USD | -273.679% |
| Humacyte, Inc. | -110.77 Million USD | -297.416% |
| Immunocore Holdings plc | -55.28 Million USD | -696.285% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2347.965% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1819.855% |
| Blueprint Medicines Corporation | -506.98 Million USD | 13.165% |
| CalciMedica, Inc. | -34.35 Million USD | -1181.375% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -550.524% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -211.334% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -165.544% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -55.422% |
| Pulmatrix, Inc. | -14.12 Million USD | -3017.64% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1150.865% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -432.736% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 8.51% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -319.794% |
| Cytokinetics, Incorporated | -526.24 Million USD | 16.343% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1120.69% |
| Nutriband Inc. | -5.48 Million USD | -7925.83% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -989.169% |
| Vor Biopharma Inc. | -117.86 Million USD | -273.52% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 110.123% |
| Evogene Ltd. | -23.87 Million USD | -1743.637% |
| ProKidney Corp. | -35.46 Million USD | -1141.237% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -267.594% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -5511.474% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 31.555% |
| CorMedix Inc. | -46.33 Million USD | -850.042% |
| BioLineRx Ltd. | -60.61 Million USD | -626.304% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -332.696% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -972.035% |
| Atai Life Sciences N.V. | -40.22 Million USD | -994.476% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -445.866% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -482.94% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -50.669% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1479.287% |
| MediciNova, Inc. | -8.57 Million USD | -5036.104% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -257.116% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5155.47% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1595.406% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -84.018% |
| Biomea Fusion, Inc. | -117.25 Million USD | -275.457% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 29.742% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1394.068% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -187.436% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -110.28% |
| Absci Corporation | -110.56 Million USD | -298.171% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1360.172% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -336.588% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -86.593% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3225.831% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -128.15% |
| Allakos Inc. | -185.7 Million USD | -137.07% |
| Imunon, Inc. | -19.51 Million USD | -2155.919% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -352.296% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 514.775% |
| BioAtla, Inc. | -123.46 Million USD | -256.581% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3516.833% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -2638.164% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -34.522% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1091.486% |
| XOMA Corporation | -40.83 Million USD | -978.205% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -332.161% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -271.471% |
| aTyr Pharma, Inc. | -50.38 Million USD | -773.687% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -402.107% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -190.093% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -85.183% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1153.572% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -5340.5% |
| Akari Therapeutics, Plc | -10 Million USD | -4298.901% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -653805.681% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 256.339% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -6505.381% |
| UroGen Pharma Ltd. | -102.24 Million USD | -330.58% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -312.239% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -5560.686% |
| Orgenesis Inc. | -55.36 Million USD | -695.22% |
| Entera Bio Ltd. | -8.88 Million USD | -4852.661% |
| GH Research PLC | -35.58 Million USD | -1137.087% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2012.486% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -468.876% |
| Xencor, Inc. | -126.08 Million USD | -249.157% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -11590.835% |
| Replimune Group, Inc. | -215.79 Million USD | -104.01% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1970.116% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 17646.513% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -6505.381% |
| Portage Biotech Inc. | -75.33 Million USD | -484.348% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5155.47% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -355.478% |
| OncoCyte Corporation | -27.78 Million USD | -1484.687% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3181.173% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -3858.47% |
| Purple Biotech Ltd. | -19.88 Million USD | -2114.497% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -6172.147% |
| scPharmaceuticals Inc. | -54.81 Million USD | -703.215% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2414.786% |
| HilleVax, Inc. | -123.56 Million USD | -256.281% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -4255.813% |
| Tharimmune, Inc. | -9.31 Million USD | -4624.086% |
| Genprex, Inc. | -30.86 Million USD | -1326.557% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -86.603% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1362.89% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -24604.938% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -8212.703% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2616422.817% |
| Savara Inc. | -54.69 Million USD | -704.859% |
| Curis, Inc. | -47.41 Million USD | -828.526% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1359.621% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -2750.369% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -7805.225% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1376.579% |
| BeiGene, Ltd. | -881.7 Million USD | 50.069% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1967.446% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -0.888% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -457.586% |
| Erasca, Inc. | -125.04 Million USD | -252.075% |
| bluebird bio, Inc. | -211.91 Million USD | -107.747% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -8703.965% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 362.604% |
| DBV Technologies S.A. | -72.72 Million USD | -505.343% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -8703.965% |
| Moderna, Inc. | -4.71 Billion USD | 90.661% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -996.302% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -7631.682% |
| Molecular Templates, Inc. | -8.12 Million USD | -5319.03% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -629.022% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -295.194% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -225.257% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -818.721% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -211.281% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -128.804% |
| MacroGenics, Inc. | -9.05 Million USD | -4760.256% |
| RenovoRx, Inc. | -10.23 Million USD | -4202.6% |
| Adicet Bio, Inc. | -142.65 Million USD | -208.6% |
| Prime Medicine, Inc. | -198.13 Million USD | -122.195% |
| Aditxt, Inc. | -32.38 Million USD | -1259.576% |
| Adagene Inc. | -18.94 Million USD | -2223.622% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5921.043% |
| Quantum-Si incorporated | -95.96 Million USD | -358.777% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -269.861% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2919.955% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 432.685% |
| SciSparc Ltd. | -5.12 Million USD | -8495.119% |
| Vericel Corporation | -3.18 Million USD | -13735.387% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -365993.436% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1367.212% |
| Generation Bio Co. | -126.61 Million USD | -247.71% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -503.973% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -434.002% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -67.942% |
| Invivyd, Inc. | -198.64 Million USD | -121.625% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -28.736% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -4968.075% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2030.378% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -4358.598% |
| 2seventy bio, Inc. | -217.57 Million USD | -102.345% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1458.986% |
| Clene Inc. | -49.5 Million USD | -789.306% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1875.283% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -790.565% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1595.406% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -34.193% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1252.805% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2037.685% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -345.626% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -488.921% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -173.774% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 28.423% |
| Evaxion Biotech A/S | -22.12 Million USD | -1889.794% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -445.286% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -120.046% |
| Trevena, Inc. | -40.28 Million USD | -992.71% |
| Surrozen, Inc. | -43.04 Million USD | -922.82% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -536.795% |
| Cingulate Inc. | -23.53 Million USD | -1770.588% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -6269.242% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1004.471% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -5609.515% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -388.019% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -618.34% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -639.865% |
| Clearmind Medicine Inc. | -11.95 Million USD | -3582.483% |
| Kronos Bio, Inc. | -112.67 Million USD | -290.725% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -536.215% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -17358026.037% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -412.535% |
| Statera Biopharma, Inc. | -174.4 Million USD | -152.421% |
| ImmunityBio, Inc. | -583.19 Million USD | 24.512% |
| Korro Bio, Inc. | -81.17 Million USD | -442.357% |
| Kineta, Inc. | -14.09 Million USD | -3022.505% |
| BioVie Inc. | -32.12 Million USD | -1270.594% |
| Codexis, Inc. | -76.24 Million USD | -477.442% |
| Celularity Inc. | -196.29 Million USD | -124.276% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -105.213% |
| Celcuity Inc. | -63.77 Million USD | -590.26% |
| Virax Biolabs Group Limited | -6.73 Million USD | -6438.05% |
| Cibus, Inc. | -267.62 Million USD | -64.498% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -991.708% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1129.349% |
| IN8bio, Inc. | -30 Million USD | -1367.131% |
| Kodiak Sciences Inc. | -260.49 Million USD | -69.005% |
| Annexon, Inc. | -134.23 Million USD | -227.959% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -275.745% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -619.021% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1295.644% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -20.191% |
| Eyenovia, Inc. | -27.26 Million USD | -1514.909% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2139.007% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -82188.224% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -476.203% |
| Arcellx, Inc. | -70.69 Million USD | -522.778% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -962.334% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -228.991% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1365.666% |
| Moolec Science SA | -51.78 Million USD | -750.071% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -740.622% |
| Geron Corporation | -184.12 Million USD | -139.097% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -948.845% |
| Royalty Pharma plc | 1.13 Billion USD | 138.794% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -223.812% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -4851.099% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1972.387% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -156.447% |
| Humacyte, Inc. | -110.77 Million USD | -297.416% |
| Structure Therapeutics Inc. | -89.62 Million USD | -391.232% |
| 89bio, Inc. | -142.18 Million USD | -209.617% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -538.402% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4142.479% |
| Genelux Corporation | -28.29 Million USD | -1455.79% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1414.681% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -148.557% |
| Notable Labs, Ltd. | -11.26 Million USD | -3808.398% |
| Liquidia Corporation | -78.5 Million USD | -460.804% |
| Mustang Bio, Inc. | -51.6 Million USD | -753.149% |
| Immunovant, Inc. | -259.33 Million USD | -69.757% |
| Quantum-Si incorporated | -95.96 Million USD | -358.777% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -504.321% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2171.513% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -358.633% |
| Acasti Pharma Inc. | -12.85 Million USD | -3325.208% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1860.303% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2658.122% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -141.37% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -10134.575% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -3430.409% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1392.801% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1029.173% |
| PepGen Inc. | -78.62 Million USD | -459.919% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1378.861% |
| United Therapeutics Corporation | 984.8 Million USD | 144.704% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1877.727% |
| Solid Biosciences Inc. | -96.01 Million USD | -358.514% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9088.044% |
| Immuneering Corporation | -53.47 Million USD | -723.319% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -8554.207% |
| Silo Pharma, Inc. | -3.7 Million USD | -11796.236% |
| Belite Bio, Inc | -31.63 Million USD | -1291.762% |
| XOMA Corporation | -40.83 Million USD | -978.205% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -709.789% |
| Bionomics Limited | -15.49 Billion USD | 97.158% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -424.191% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1409.902% |
| uniQure N.V. | -308.47 Million USD | -42.714% |
| Cassava Sciences, Inc. | -97.21 Million USD | -352.845% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5921.043% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -256.673% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1298.659% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -5267.69% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1414.525% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -82188.224% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1578.263% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2570.561% |
| Altimmune, Inc. | -88.44 Million USD | -397.747% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -190.428% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1409.902% |
| Compugen Ltd. | -18.75 Million USD | -2247.457% |
| Peak Bio, Inc. | -1259.26 USD | -34960273.553% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -856.029% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1924.008% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -29.945% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -430.706% |
| Zura Bio Limited | -60.36 Million USD | -629.361% |
| PolyPid Ltd. | -23.86 Million USD | -1744.718% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2698.385% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -430.706% |
| Instil Bio, Inc. | -156.08 Million USD | -182.049% |
| argenx SE | -295.05 Million USD | -49.208% |
| Immunome, Inc. | -106.8 Million USD | -312.188% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -936.01% |
| Verona Pharma plc | -54.36 Million USD | -709.73% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -340.608% |
| Shattuck Labs, Inc. | -87.29 Million USD | -404.298% |
| CervoMed Inc. | -2.17 Million USD | -20170.154% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -253.18% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3206.113% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -910.773% |
| Moolec Science SA | -51.78 Million USD | -750.071% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2545868.506% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -225.822% |
| AnaptysBio, Inc. | -163.61 Million USD | -169.065% |
| Design Therapeutics, Inc. | -66.86 Million USD | -558.434% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -440.745% |
| NeurAxis, Inc. | -14.62 Million USD | -2909.855% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1062.14% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1193.536% |
| Achilles Therapeutics plc | -69.66 Million USD | -531.941% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -340.608% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2108.375% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 14731.862% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -17358026.037% |
| Nutriband Inc. | -5.48 Million USD | -7925.83% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -337.195% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -805.717% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -471.068% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1195.973% |
| MoonLake Immunotherapeutics | -36 Million USD | -1122.648% |
| Palisade Bio, Inc. | -12.3 Million USD | -3479.203% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -945.11% |
| Beam Therapeutics Inc. | -132.52 Million USD | -232.19% |
| Neurogene Inc. | -36.31 Million USD | -1112.22% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -169.401% |
| AEON Biopharma, Inc. | -52.55 Million USD | -737.663% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -348.554% |
| Sesen Bio, Inc. | -19.88 Million USD | -2114.051% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -515.001% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -3418.025% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 0.855% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -294.602% |
| Athira Pharma, Inc. | -117.67 Million USD | -274.126% |
| Vaccinex, Inc. | -20.25 Million USD | -2073.927% |
| HCW Biologics Inc. | -24.99 Million USD | -1661.371% |
| XOMA Corporation | -40.83 Million USD | -978.205% |
| Nektar Therapeutics | -276.05 Million USD | -59.476% |
| Arvinas, Inc. | -367.3 Million USD | -19.859% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -653805.681% |
| Merus N.V. | -154.93 Million USD | -184.139% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -351.864% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1302.715% |
| Rezolute, Inc. | -68.45 Million USD | -543.074% |
| Clene Inc. | -49.5 Million USD | -789.306% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2754.364% |
| BeyondSpring Inc. | -21.02 Million USD | -1993.798% |
| Synlogic, Inc. | -57.28 Million USD | -668.552% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -3599.202% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3966.525% |
| Peak Bio, Inc. | -1259.26 USD | -34960273.553% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1078.126% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4127.095% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -207.649% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -35.416% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -9431.183% |
| MannKind Corporation | -11.93 Million USD | -3587.737% |
| Ikena Oncology, Inc. | -68.16 Million USD | -545.838% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1994.894% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -373.72% |
| Gossamer Bio, Inc. | -179.81 Million USD | -144.828% |
| CohBar, Inc. | -11.96 Million USD | -3580.301% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1607.158% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1360.172% |
| Legend Biotech Corporation | -518.25 Million USD | 15.053% |
| Mural Oncology plc | -207.44 Million USD | -112.219% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -254.705% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2307.045% |
| Disc Medicine, Inc. | -76.42 Million USD | -476.014% |
| Champions Oncology, Inc. | -7.27 Million USD | -5950.605% |
| REGENXBIO Inc. | -263.49 Million USD | -67.079% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4048.11% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -826.728% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1059.035% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -339.526% |
| Vaxart, Inc. | -82.46 Million USD | -433.853% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 132002.578% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1072.649% |
| Cellectis S.A. | -101.05 Million USD | -335.629% |
| Longeveron Inc. | -21.41 Million USD | -1955.957% |
| Repare Therapeutics Inc. | -93.79 Million USD | -369.361% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 17.862% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -518.587% |
| Revolution Medicines, Inc. | -436.36 Million USD | -0.888% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -6599.772% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1328.244% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -534.967% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -580.099% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -4387.229% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 112.163% |
| Denali Therapeutics Inc. | -145.22 Million USD | -203.147% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -365993.436% |
| Veru Inc. | -93.15 Million USD | -372.603% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1528.776% |
| Cingulate Inc. | -23.53 Million USD | -1770.588% |
| Passage Bio, Inc. | -102.06 Million USD | -331.348% |
| Context Therapeutics Inc. | -23.96 Million USD | -1737.081% |
| Exicure, Inc. | -16.91 Million USD | -2502.826% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -133.035% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1065.772% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -6665.33% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -138.384% |
| Nuvalent, Inc. | -126.21 Million USD | -248.792% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4086.539% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -406.73% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1341.337% |
| OmniAb, Inc. | -50.61 Million USD | -769.717% |
| Anew Medical, Inc. | 1.34 Million USD | 32804.392% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2643.796% |
| Lipocine Inc. | -16.35 Million USD | -2592.269% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -563.075% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -591.389% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -943.381% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -817.802% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2119.969% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 18.698% |
| Ocugen, Inc. | -63.07 Million USD | -597.933% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -359.869% |
| Q32 Bio Inc. | -112.96 Million USD | -289.729% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2460.738% |
| Alumis Inc. Common Stock | -154.99 Million USD | -184.04% |
| Equillium, Inc. | -13.33 Million USD | -3201.402% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -629.288% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -5411.405% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2235.349% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -645.137% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -284.4% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2295.49% |
| Dominari Holdings Inc. | -22.88 Million USD | -1823.966% |
| Edesa Biotech, Inc. | -8.37 Million USD | -5156.988% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2074.035% |
| Bio-Techne Corporation | 168.1 Million USD | 361.885% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -25.037% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 441.662% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -261.352% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1060.394% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -290.833% |
| Nkarta, Inc. | -117.5 Million USD | -274.671% |
| BioCardia, Inc. | -11.57 Million USD | -3704.701% |
| Iterum Therapeutics plc | -38.37 Million USD | -1047.33% |